132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: Substance Abuse Treatment Experiences Poster Session
4095.0: Tuesday, November 9, 2004: 12:30 PM-2:00 PM
Substance Abuse Treatment Experiences Poster Session
Learning Objectives: See individual abstracts.
Board 1Office-based buprenorphine treatment for opiate dependency: Policy to practice challenges in an urban setting
Marilyn Ann DeLuca, PhD, RN, Andrew J. Kolodny, MD
Board 2Buprenorphine-assisted recruitment of opioid-dependent patients into residential treatment: The First Step model at Phoenix House
Terry Horton, MD, Eric D. Collins, MD, Katherine Reinke, MS, RN, Edward V. Nunes, MD, Leslie Amass, PhD
Board 3Office-based opioid treatment: New interventions to treat prescription opioid abuse
C. Danielle Johnson, MPH, Nicholas Reuter, MPH
Board 4Eighty-four cost outcome analyses in substance abuse prevention and acute harm reduction
Ted R. Miller, PhD, Delia Hendrie
Board 5Summer time and the buyin's easy: Lessons learned from the Youth Health Advisory Council survey on youth access to ATOD in Marin County
Margaret Libby, MSW, Maureen Sedonaen
Board 6Effective alternatives: Utilizing social marketing strategies to implement a prenatal substance abuse referral project in medical offices
Augustine McDaniel-Smith, MBA, Tamarra C. Jones, MPH, CHES, Rachel Gonzales, MPH, Amy S. Myerson, MA
Board 7Community participatory activities (CPA) and ATOD use among adolescents
Mian B. Hossain, MSC, MHS, PhD, Joy P. Nanda, DSc, MS, MHS, Ava Joubert-Curtis, MD, Ivana Amaris Vaughn, MPH(c), Kia Tolson, MPH, J. Prince James, MPH, Jamaal A. Russell, MPH, MT, Sharrone Bryant, MA, MS
Board 8Attitudes toward ibogaine among clients and counselors in drug treatment programs
Marilyn C. Daley, PhD, Dennis McCarty, PhD, Cindy Parks Thomas, PA, PhD, Traci Rieckmann, PhD
Board 9Twelve month outcomes of fully, partially and minimally integrated approaches to treating persons with co-occurring mental health and substance abuse disorders
Roy M. Gabriel, PhD, Kelly Vander Ley, PhD, Jennifer Lembach, BA
Board 10Modelling of responses in risk behaviour indicators subject to measurement errors
Perpetual Chikobvu, PhD, Carl Lombard, PhD, Alan J. Flisher, PhD, Loraine Townsend, MA, Martie Muller, MSc, Gary King, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Alcohol, Tobacco, and Other Drugs

The 132nd Annual Meeting (November 6-10, 2004) of APHA